What is the Share Price of Sai Life Sciences Ltd?
- Answer Field
-
The share price of Sai Life Sciences Ltd for NSE is ₹ 696.8 and for BSE is ₹ 697.15.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, SAI LIFE SCIENCES LIMITED share price is currently at ₹ 696.8, which is down by ₹ -17.50 from its previous closing. Today, the stock has fluctuated between ₹ 694.00 and ₹ 719.05. Over the past year, SAI LIFE SCIENCES LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been -5.60 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 428.60 |
Operating Expense | 370.14 |
Net Profit | 51.06 |
Net Profit Margin (%) | 11.91 |
Earnings Per Share (EPS) | 2.74 |
EBITDA | 120.63 |
Effective Tax Rate (%) | 24.82 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 19.95 | 2.02 | 284.31 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 122.65 | 16.07 | 1.27 | 1292.37 | 92.25 / 184.95 |
CIPLA LTD | 1541.00 | 24.94 | 4.38 | 124457.39 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 272.25 | 22.56 | 2.76 | 801.26 | 145.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 37.10 | 22.35 | 6.30 | 284.31 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 679.10 | 39.81 | 6.59 | 1963.32 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8795.90 | 131.18 | 32.36 | 21989.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 122.65 | 15.93 | 1.26 | 1292.37 | 92.25 / 184.95 |
Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003.
Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh. Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company is an innovator-focused contract research, development, and manufacturing organization (CRDMO). The Company provide end-to-end services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both (a) discovery / contract research and (b) CMC / CDMO capabilities.
Through the Scheme of Amalgamation, Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later, the Company opened new areas of biology facility in Watertown (Greater Boston, MA) U.S.A. for innovative and creative small-molecule drugs in 2019. It launched Sai Nxt, an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge, Massachusetts, USA.
In 2021, the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022, it opened the first set of new disconvery chemistry labs at Unit III Plant, Hyderabad.
In 2023, the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability & formulations (D&F) capabilities at Unit II Hyderabad in 2024.
The Company is proposing to raise money from public through IPO by issue and allotment of 61,573,120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares.
The share price of Sai Life Sciences Ltd for NSE is ₹ 696.8 and for BSE is ₹ 697.15.
The market cap of Sai Life Sciences Ltd for NSE is ₹ 12,30.76 Cr. and for BSE is ₹ 12,31.37 Cr. as of now.
The 52 Week High and Low of Sai Life Sciences Ltd for NSE is ₹ 808.80 and ₹ 636.10 and for BSE is ₹ 808.20 and ₹ 635.30.
You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 0.00%.
Sai Life Sciences Ltd share price is for NSE ₹ 696.8 & for BSE ₹ 697.15 as on Apr 30 2025 03:30 PM.
The market cap of Sai Life Sciences Ltd for NSE ₹ 12,30.76 & for BSE ₹ 12,31.37 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Sai Life Sciences Ltd share is 102.61.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Sai Life Sciences Ltd share is 94.14.
You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a demat account.
To buy Sai Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Sai Life Sciences Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found